Ashwagandha

by Savesta · capsule · 60 vegetarian capsules

  • Off the market since October 2023 (NIH)
  • UPC 7 04849 00013 8
  • DSLD label 18666
  • Serving 1 capsule

Ashwagandha by Savesta lists 2 ingredients, 2 with an amount per serving of 1 capsule, such as 500 mg of ashwagandha (withania somnifera) root extract. Its current label entered the NIH Dietary Supplement Label Database on February 25, 2013.

What is in Ashwagandha?

Each row as the label prints it, per serving of 1 capsule. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Ashwagandha: Supplement Facts rows against the market (DSLD label 18666, January 2026 release)
IngredientAmount% DVAmong products listing it
Ashwagandha (Withania somnifera) root extract500 mgAshwagandha in Ashwagandha against 1,646 products500 mg per serving; the middle half of products list 125 mg to 500 mg, the median 250 mg.500 mg

Higher than 74% of 1,646 products listing ashwagandha (median 250 mg). Per day at the most servings: 1,000 mg.

5% Withanolides25 mgWithanolide in Ashwagandha against 79 products25 mg per serving; the middle half of products list 3.13 mg to 20 mg, the median 8 mg.25 mg

Higher than 78% of 79 products listing withanolide (median 8 mg). Per day at the most servings: 50 mg.

Source: NIH ODS Dietary Supplement Label Database, label 18666 (entered February 25, 2013), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records 1 to 2 servings a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

6 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Directions: 1 capsule, one to two times per day or as directed by your health care practitioner.
Warnings
Caution: Not for use during pregnancy. If you are nursing or taking any prescription drugs, seek the advice of a health professional before using this product.
Keep out of reach of children.
Allergens and what it does not contain
Soy, wheat, gluten and GMO free.

Source: label statements in DSLD label 18666.

What else is on the label?

Other ingredients: vegetarian capsules, Silicon Dioxide, L-Leucine, bamboo leaf extract, Microcrystalline Cellulose.

How many labels does Ashwagandha have?

One label is on file, entered on February 25, 2013.

  1. Label 18666 (current) Entered February 25, 2013 · off the market October 16, 2023 · 60 vegetarian capsules · UPC 7 04849 00013 8

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Savesta LifeSciences Inc. (manufacturer, distributor), Chatsworth, CA. All Savesta products.

Where next?